AbbVie (ABBV) Non-Current Debt (2012 - 2026)

AbbVie (ABBV) has 15 years of Non-Current Debt data on file, last reported at $64.5 billion in Q1 2026.

• Non-Current Debt for Q1 2026 came in at $64.5 billion, changed 0.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.5 billion (changed 0.01% YoY), and the FY2025 annual result was $58.9 billion, down 2.32% from the prior year.
• Non-Current Debt climbed to $64.5 billion in Q1 2026 per ABBV's latest filing, from $58.9 billion in the prior quarter.
• Over five years, Non-Current Debt peaked at $64.5 billion in Q1 2026 and troughed at $52.2 billion in Q4 2023.
• A 5-year average of $60.1 billion and a median of $60.3 billion in 2024 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2022 and 2024: Non-Current Debt slipped 18.43% in 2022, then climbed 15.61% in 2024.
• A 5-year view of Non-Current Debt shows it stood at $59.1 billion in 2022, then declined by 11.74% to $52.2 billion in 2023, then gained by 15.61% to $60.3 billion in 2024, then slipped by 2.32% to $58.9 billion in 2025, then rose by 9.49% to $64.5 billion in 2026.
• Business Quant data shows ABBV's Non-Current Debt at $64.5 billion in Q1 2026, $58.9 billion in Q4 2025, and $63.0 billion in Q3 2025.